Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Non-Current Liabilities: 2015-2019

Historic Other Non-Current Liabilities for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $3.9 million.

  • Outlook Therapeutics' Other Non-Current Liabilities fell 95.45% to $181,098 in Q2 2020 from the same period last year, while for Jun 2020 it was $181,098, marking a year-over-year decrease of 95.45%. This contributed to the annual value of $3.9 million for FY2019, which is 12.18% up from last year.
  • According to the latest figures from FY2019, Outlook Therapeutics' Other Non-Current Liabilities is $3.9 million, which was up 12.18% from $3.5 million recorded in FY2018.
  • Outlook Therapeutics' Other Non-Current Liabilities' 5-year high stood at $3.9 million during FY2019, with a 5-year trough of $284,710 in FY2015.
  • Over the past 3 years, Outlook Therapeutics' median Other Non-Current Liabilities value was $3.5 million (recorded in 2018), while the average stood at $3.3 million.
  • Data for Outlook Therapeutics' Other Non-Current Liabilities shows a peak YoY soared of 754.93% (in 2016) over the last 5 years.
  • Yearly analysis of 5 years shows Outlook Therapeutics' Other Non-Current Liabilities stood at $284,710 in 2015, then skyrocketed by 754.93% to $2.4 million in 2016, then climbed by 5.58% to $2.6 million in 2017, then surged by 36.76% to $3.5 million in 2018, then grew by 12.18% to $3.9 million in 2019.